Affinia Therapeutics Names New Chief Business & Financial Officer
Affinia Therapeutics, an innovative company with a proprietary platform pioneering a shift to a new class of rationally-designed gene therapies...
Financial
Building a stronger brand: The power of financial management and CSR
Success Ajilore is a highly seasoned accounting professional and business analyst with over eleven years of experience specialising in enhancing...
AI in Financial Modeling: Applications, Benefits, and Development
Using AI in the financial modeling process can improve efficiencies and insights, but models must still be reviewed by analysts...
BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hosted an Investor Day earlier today, where President...
Japan Financial Markets | Business & Finance
State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed Forces PacificArmed...
The financial and capital markets remain unstable
The Bank of Japan (BoJ) Deputy Governor Ryozo Himino said on Wednesday that the financial and capital markets remain unstable and the Japanese...
New financial analytics and reporting in Microsoft Dynamics 365 Business Central
How CFOs and finance leaders can make data-driven decisions and optimize business performance. Why being data driven is key for...
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
BEIJING, Aug. 16, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company...
Opinion | As Hong Kong looks to regain financial crown, HKEX can win big with data
The opportunity for all exchange operators, including HKEX, is to graduate from an intermediary that merely facilitates trading and listings,...
